1 / 2

人參及人參皂苷 ;Rg1 合併去氫羥化腎上腺皮素在純系小鼠之馬兜鈴酸腎炎模型之藥效評估

人參及人參皂苷 ;Rg1 合併去氫羥化腎上腺皮素在純系小鼠之馬兜鈴酸腎炎模型之藥效評估.

adena-chang
Télécharger la présentation

人參及人參皂苷 ;Rg1 合併去氫羥化腎上腺皮素在純系小鼠之馬兜鈴酸腎炎模型之藥效評估

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 人參及人參皂苷;Rg1合併去氫羥化腎上腺皮素在純系小鼠之馬兜鈴酸腎炎模型之藥效評估人參及人參皂苷;Rg1合併去氫羥化腎上腺皮素在純系小鼠之馬兜鈴酸腎炎模型之藥效評估 • 馬兜鈴酸 (aristolochic acid, AA) 在中草藥引起的腎病變中扮演重要的角色。本研究為藉由投予AA引起馬兜鈴酸腎病變 (aristolochic acid nephropathy, AAN) 後評估人參濃縮劑 (ginseng extrat, GE) 及其成分人參皂苷Rg1 (ginsenoside, GS) ，並分別與去氫羥化腎上腺皮質素 (Prednisolone, P) 合併對AAN的改善效果。純系小鼠C3H/He (6 week-old male) 給予3.0 μg/mL AA作為飲用水連續56天，之後治療組連續14天經口分別投予GE 250 mg/kg、GS 5 mg/kg、prednisolone 2 mg/kg 及prednisolone合併GE或GS；對照組在前56天同樣予以AA作為飲用水，在投予治療藥物期間則給予等量蒸餾水；Normal組則是在整個實驗過程皆給予蒸餾水。藉由測定尿蛋白，尿中N-acetyl-beta-D-glucosaminidase (NAG) 與血中blood urea nitrogen (BUN) 及creatinine，以評估小鼠腎功能；腎組織使用PAS染色觀察病理組織改變，並進行免疫螢光染色 (TGF-β，MMP-9，HGF)，以辨識損傷部位之特異性抗原。實驗結果顯示，以GE，P，GE+P及GS+P對尿蛋白、NAG、BUN及SCr值皆能有效降低；組織學觀察各組腎組織損傷的情形皆有緩解現象；免疫螢光染色觀察發現TGF-β沈積情形降低，MMP-9及HGF的沈積增加。根據上述結果得知以合併治療組在各實驗中皆有較佳療效，推測應是GE及GS結構類似prednisolone具有抗發炎效果，可以減少基質堆積並延緩纖維化過程以降低腎臟損傷程度，且與prednisolone合併使用可有加成療效。

  2. Effect of ginseng, ginsenoside Rg1 and prednisolone on aristolochic acid induced nephropathy in inbred mice • Aristolochic acid (AA) has been demonstrated to play an important • role in aristolochic acid nephropathy (AAN). The purpose of this study was to evaluate the therapeutic effect of ginseng extract (GE) or its active component ginsenoside Rg1 (GS), combined with prednisolone on AAN. • AA was dissolved in distilled water as drinking water to C3H/HE mice (6 week-old male) for 56 days. The treatment groups in phase one were administered with GE 250mg/kg, prednisolone 2mg/kg, and both GE and prednisolone orally for 14 days. In phase two, under the same process, GE was replaced by GS. The control group was administered with distilled water and the normal group was only administered with distilled water throughout the experiment. Urine protein, urine N-acetyl-beta-D-glucosaminidase (NAG), blood urea nitrogen (BUN) and serum creatinine were determined to evaluate renal function. Renal tissues were served to histological examination (PAS stain and immunofluorescence). The antibodies, including TGF-β (transforming growth factor-β), MMP-9 (matrix metalloproteinase-9), HGF (hepatocyte growth factor), were chosen to recognize the specific antigens in injury sites.Compared with the control group, urine protein, NAG, BUN and serum creatinine were decreased at different level in all treatment groups. In the histological examination, we observed the alleviation in all treatment groups. The fluorescence dots of TGF-β were significantly decreased and MMP-9, HGF were significantly increased in experimental groups. Based on our result, both GE and GS combined with prednisolone has the superior effect among the concomitance groups. Our findings demonstrated that GE and GS are structure analogs of prednisolone and they have anti-inflammatory properties to slow down the fibrosis process and repair the renal injury.

More Related